| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mosquito Control | 8 | 2014 | 36 | 2.520 |
Why?
|
| Culicidae | 8 | 2015 | 75 | 2.330 |
Why?
|
| Neurology | 3 | 2021 | 121 | 1.880 |
Why?
|
| Nervous System Diseases | 5 | 2024 | 412 | 1.430 |
Why?
|
| Insect Vectors | 6 | 2014 | 114 | 1.380 |
Why?
|
| Cannabidiol | 6 | 2024 | 22 | 1.030 |
Why?
|
| Aedes | 5 | 2014 | 109 | 1.020 |
Why?
|
| Microtubule-Associated Proteins | 13 | 2009 | 258 | 1.010 |
Why?
|
| Platelet Activating Factor | 10 | 2003 | 27 | 1.010 |
Why?
|
| Moyamoya Disease | 2 | 2018 | 42 | 0.890 |
Why?
|
| Rare Diseases | 4 | 2024 | 207 | 0.740 |
Why?
|
| Exome | 6 | 2024 | 1068 | 0.710 |
Why?
|
| Seizures | 6 | 2023 | 890 | 0.700 |
Why?
|
| Anticonvulsants | 5 | 2024 | 393 | 0.670 |
Why?
|
| Cerebral Cortex | 7 | 2009 | 483 | 0.640 |
Why?
|
| Botulism | 1 | 2018 | 9 | 0.610 |
Why?
|
| Stroke | 3 | 2021 | 1075 | 0.610 |
Why?
|
| Cranial Nerve Diseases | 1 | 2018 | 27 | 0.600 |
Why?
|
| Cockayne Syndrome | 1 | 2018 | 6 | 0.590 |
Why?
|
| Insecticides | 3 | 2014 | 62 | 0.590 |
Why?
|
| Neurons | 15 | 2024 | 2049 | 0.550 |
Why?
|
| Mutation | 11 | 2023 | 6305 | 0.550 |
Why?
|
| Hospitals, Pediatric | 1 | 2021 | 791 | 0.510 |
Why?
|
| Hippocampus | 14 | 2008 | 863 | 0.510 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 12 | 2009 | 94 | 0.510 |
Why?
|
| Whole Genome Sequencing | 3 | 2024 | 325 | 0.470 |
Why?
|
| Child | 32 | 2024 | 25843 | 0.460 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2019 | 532 | 0.460 |
Why?
|
| Telemedicine | 1 | 2021 | 500 | 0.460 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 6 | 2009 | 83 | 0.450 |
Why?
|
| Brain Diseases | 3 | 2022 | 310 | 0.440 |
Why?
|
| Extracellular Matrix Proteins | 6 | 2009 | 161 | 0.440 |
Why?
|
| Recreation | 1 | 2014 | 21 | 0.440 |
Why?
|
| Interviews as Topic | 2 | 2024 | 420 | 0.430 |
Why?
|
| Abnormalities, Multiple | 6 | 2016 | 976 | 0.430 |
Why?
|
| Transcription Factors | 2 | 2016 | 2729 | 0.430 |
Why?
|
| Internship and Residency | 2 | 2021 | 1250 | 0.420 |
Why?
|
| Brain | 10 | 2019 | 3227 | 0.420 |
Why?
|
| Developmental Disabilities | 6 | 2018 | 734 | 0.420 |
Why?
|
| Humans | 71 | 2024 | 134085 | 0.400 |
Why?
|
| Pest Control, Biological | 1 | 2012 | 18 | 0.400 |
Why?
|
| Latin America | 4 | 2014 | 99 | 0.390 |
Why?
|
| Child, Preschool | 24 | 2024 | 14838 | 0.380 |
Why?
|
| Pediatrics | 1 | 2021 | 1215 | 0.370 |
Why?
|
| Tuberous Sclerosis | 2 | 2024 | 124 | 0.360 |
Why?
|
| Holoprosencephaly | 1 | 2011 | 24 | 0.360 |
Why?
|
| Nervous System Malformations | 2 | 2004 | 131 | 0.360 |
Why?
|
| Animals | 39 | 2023 | 36543 | 0.360 |
Why?
|
| Receptors, Cell Surface | 5 | 2007 | 497 | 0.350 |
Why?
|
| Infant | 20 | 2024 | 13201 | 0.350 |
Why?
|
| Rhombencephalon | 1 | 2011 | 50 | 0.350 |
Why?
|
| Phospholipases A | 3 | 2003 | 39 | 0.350 |
Why?
|
| Community Mental Health Services | 2 | 2024 | 41 | 0.350 |
Why?
|
| Infarction, Anterior Cerebral Artery | 1 | 2010 | 2 | 0.340 |
Why?
|
| Epileptic Syndromes | 2 | 2022 | 32 | 0.340 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 65 | 0.330 |
Why?
|
| Female | 40 | 2024 | 71851 | 0.320 |
Why?
|
| Cerebral Arteries | 1 | 2010 | 82 | 0.320 |
Why?
|
| Family | 1 | 2023 | 589 | 0.320 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 2000 | 33 | 0.320 |
Why?
|
| Diterpenes | 3 | 1998 | 29 | 0.310 |
Why?
|
| Family Characteristics | 3 | 2014 | 91 | 0.310 |
Why?
|
| Male | 38 | 2024 | 66057 | 0.310 |
Why?
|
| Focus Groups | 2 | 2024 | 212 | 0.300 |
Why?
|
| Angioplasty, Balloon | 1 | 2010 | 162 | 0.300 |
Why?
|
| Epilepsies, Myoclonic | 3 | 2018 | 25 | 0.300 |
Why?
|
| Feathers | 1 | 2008 | 7 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 7 | 2011 | 1164 | 0.290 |
Why?
|
| Information Dissemination | 6 | 2020 | 198 | 0.290 |
Why?
|
| Biological Factors | 1 | 2008 | 27 | 0.290 |
Why?
|
| Serine Endopeptidases | 6 | 2009 | 204 | 0.280 |
Why?
|
| Proteins | 5 | 2002 | 1098 | 0.280 |
Why?
|
| Chickens | 1 | 2008 | 640 | 0.280 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2000 | 315 | 0.280 |
Why?
|
| Epilepsy | 4 | 2023 | 893 | 0.270 |
Why?
|
| Quality of Life | 2 | 2014 | 2157 | 0.270 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 680 | 0.270 |
Why?
|
| Compassionate Use Trials | 2 | 2024 | 15 | 0.270 |
Why?
|
| Intellectual Disability | 4 | 2019 | 1078 | 0.260 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 176 | 0.250 |
Why?
|
| Genomics | 2 | 2023 | 1669 | 0.250 |
Why?
|
| Parents | 1 | 2023 | 1070 | 0.250 |
Why?
|
| Adult | 20 | 2024 | 31964 | 0.240 |
Why?
|
| Brain Infarction | 2 | 2019 | 31 | 0.240 |
Why?
|
| Biomedical Research | 6 | 2006 | 556 | 0.240 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 847 | 0.230 |
Why?
|
| Malformations of Cortical Development | 3 | 2011 | 54 | 0.230 |
Why?
|
| Nuclear Proteins | 2 | 2011 | 1343 | 0.230 |
Why?
|
| Adolescent | 16 | 2024 | 20601 | 0.230 |
Why?
|
| Skin | 1 | 2008 | 553 | 0.230 |
Why?
|
| Consciousness Disorders | 1 | 2004 | 26 | 0.230 |
Why?
|
| New Jersey | 2 | 2014 | 25 | 0.230 |
Why?
|
| Mutism | 1 | 2004 | 32 | 0.220 |
Why?
|
| Insect Repellents | 2 | 2015 | 36 | 0.220 |
Why?
|
| Cell Movement | 5 | 2004 | 918 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2019 | 3487 | 0.210 |
Why?
|
| Personnel Selection | 1 | 2024 | 67 | 0.210 |
Why?
|
| Influenza A virus | 1 | 2004 | 152 | 0.210 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 67 | 0.210 |
Why?
|
| Syndrome | 4 | 2016 | 1159 | 0.210 |
Why?
|
| Synapses | 4 | 2000 | 470 | 0.200 |
Why?
|
| Ferrets | 1 | 2023 | 14 | 0.200 |
Why?
|
| Phenotype | 8 | 2020 | 4556 | 0.200 |
Why?
|
| Biomarkers, Tumor | 6 | 2006 | 1721 | 0.200 |
Why?
|
| Phospholipid Ethers | 3 | 1999 | 7 | 0.200 |
Why?
|
| Infant, Newborn | 10 | 2021 | 8607 | 0.200 |
Why?
|
| Social Behavior | 2 | 2019 | 230 | 0.190 |
Why?
|
| Epilepsy, Generalized | 1 | 2022 | 65 | 0.190 |
Why?
|
| Polysaccharides | 2 | 2020 | 152 | 0.190 |
Why?
|
| Spermatogenesis | 1 | 2003 | 178 | 0.190 |
Why?
|
| Financial Management, Hospital | 1 | 2021 | 3 | 0.190 |
Why?
|
| Genetic Testing | 3 | 2024 | 1095 | 0.180 |
Why?
|
| Meningoencephalitis | 1 | 2021 | 22 | 0.180 |
Why?
|
| Lactones | 3 | 1998 | 40 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2023 | 4934 | 0.180 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2024 | 219 | 0.180 |
Why?
|
| Hedgehog Proteins | 1 | 2023 | 267 | 0.180 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2020 | 453 | 0.180 |
Why?
|
| Neurologists | 1 | 2021 | 27 | 0.180 |
Why?
|
| Chromosome Aberrations | 3 | 2009 | 626 | 0.180 |
Why?
|
| Melanosis | 1 | 2021 | 10 | 0.180 |
Why?
|
| Dog Diseases | 1 | 2021 | 60 | 0.180 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 426 | 0.180 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2021 | 16 | 0.170 |
Why?
|
| Qualitative Research | 3 | 2024 | 638 | 0.170 |
Why?
|
| Young Adult | 10 | 2024 | 9917 | 0.170 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2021 | 49 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2008 | 1049 | 0.170 |
Why?
|
| Alleles | 3 | 2018 | 1710 | 0.170 |
Why?
|
| Middle Aged | 11 | 2024 | 29402 | 0.170 |
Why?
|
| Galectins | 1 | 2020 | 26 | 0.170 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2000 | 24 | 0.170 |
Why?
|
| Pertussis Toxin | 1 | 2000 | 29 | 0.170 |
Why?
|
| Osteopathic Physicians | 1 | 2020 | 1 | 0.170 |
Why?
|
| Osteopathic Medicine | 1 | 2020 | 2 | 0.170 |
Why?
|
| Fibroblasts | 2 | 2024 | 925 | 0.170 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2020 | 25 | 0.170 |
Why?
|
| Hypoxia, Brain | 3 | 1989 | 35 | 0.160 |
Why?
|
| GTP Phosphohydrolases | 1 | 2021 | 157 | 0.160 |
Why?
|
| SOXD Transcription Factors | 1 | 2019 | 4 | 0.160 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2020 | 92 | 0.160 |
Why?
|
| Physical and Rehabilitation Medicine | 1 | 2020 | 37 | 0.160 |
Why?
|
| GTP-Binding Proteins | 1 | 2000 | 188 | 0.160 |
Why?
|
| Rats | 12 | 2000 | 3890 | 0.160 |
Why?
|
| Central Nervous System | 2 | 2023 | 286 | 0.160 |
Why?
|
| Certification | 1 | 2020 | 73 | 0.160 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 181 | 0.150 |
Why?
|
| Muscle Hypotonia | 2 | 2016 | 196 | 0.150 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 2018 | 4 | 0.150 |
Why?
|
| Genome, Human | 2 | 2024 | 1342 | 0.150 |
Why?
|
| Lennox Gastaut Syndrome | 1 | 2018 | 8 | 0.150 |
Why?
|
| Meningeal Neoplasms | 1 | 2021 | 219 | 0.150 |
Why?
|
| Aicardi Syndrome | 1 | 2018 | 15 | 0.150 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 26 | 0.140 |
Why?
|
| Influenza, Human | 1 | 2004 | 697 | 0.140 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 1998 | 35 | 0.140 |
Why?
|
| Polyvinyls | 1 | 1997 | 13 | 0.140 |
Why?
|
| Ammonia | 1 | 1998 | 77 | 0.140 |
Why?
|
| Cytoskeleton | 1 | 1999 | 175 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 384 | 0.140 |
Why?
|
| Protein Subunits | 1 | 2018 | 174 | 0.140 |
Why?
|
| Cerebellar Ataxia | 1 | 1998 | 67 | 0.140 |
Why?
|
| Cerebral Ventricles | 1 | 1997 | 84 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2018 | 376 | 0.140 |
Why?
|
| Drosophila Proteins | 1 | 2023 | 772 | 0.130 |
Why?
|
| Genitalia | 1 | 2016 | 39 | 0.130 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1998 | 115 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2021 | 1612 | 0.130 |
Why?
|
| Speech Disorders | 1 | 2016 | 49 | 0.130 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 163 | 0.130 |
Why?
|
| Health Personnel | 2 | 2024 | 541 | 0.130 |
Why?
|
| Zinc Fingers | 1 | 2016 | 125 | 0.130 |
Why?
|
| Spasms, Infantile | 1 | 2018 | 175 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 139 | 0.130 |
Why?
|
| Neoplasms | 6 | 2006 | 3037 | 0.130 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2015 | 3 | 0.120 |
Why?
|
| Premature Birth | 1 | 2020 | 418 | 0.120 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 37 | 0.120 |
Why?
|
| Synaptic Transmission | 3 | 1993 | 369 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2020 | 1250 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2016 | 94 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 116 | 0.120 |
Why?
|
| Ataxia | 1 | 2016 | 177 | 0.120 |
Why?
|
| Fetal Diseases | 3 | 2011 | 462 | 0.120 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 988 | 0.120 |
Why?
|
| Language Development Disorders | 3 | 2019 | 179 | 0.120 |
Why?
|
| Mice, Neurologic Mutants | 3 | 2007 | 74 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2021 | 1741 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2014 | 3999 | 0.110 |
Why?
|
| Chromosome Disorders | 1 | 2016 | 315 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1978 | 0.110 |
Why?
|
| Fungicides, Industrial | 1 | 2013 | 2 | 0.110 |
Why?
|
| Aged | 5 | 2023 | 21756 | 0.100 |
Why?
|
| Siblings | 2 | 2011 | 198 | 0.100 |
Why?
|
| Melanoma | 1 | 2021 | 967 | 0.100 |
Why?
|
| Amides | 1 | 2013 | 87 | 0.100 |
Why?
|
| Cerebellum | 4 | 2008 | 464 | 0.100 |
Why?
|
| Professional-Family Relations | 1 | 2023 | 96 | 0.100 |
Why?
|
| Axons | 1 | 1995 | 395 | 0.100 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 94 | 0.100 |
Why?
|
| Software | 1 | 2017 | 733 | 0.100 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2011 | 577 | 0.100 |
Why?
|
| Lipids | 1 | 1995 | 566 | 0.100 |
Why?
|
| Cells, Cultured | 7 | 2001 | 3186 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 477 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 563 | 0.090 |
Why?
|
| Cognitive Dysfunction | 1 | 2016 | 314 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2014 | 293 | 0.090 |
Why?
|
| Pregnancy | 6 | 2023 | 7568 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2016 | 871 | 0.090 |
Why?
|
| Chromosome Banding | 1 | 2011 | 140 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2011 | 3854 | 0.090 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2011 | 7 | 0.090 |
Why?
|
| Neuropeptides | 2 | 2002 | 116 | 0.090 |
Why?
|
| N-Methylaspartate | 2 | 1990 | 28 | 0.090 |
Why?
|
| Motivation | 1 | 2023 | 328 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 2174 | 0.090 |
Why?
|
| Magnesium | 2 | 1990 | 127 | 0.090 |
Why?
|
| Curriculum | 1 | 2016 | 764 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2021 | 1664 | 0.090 |
Why?
|
| Animals, Newborn | 5 | 2008 | 1044 | 0.090 |
Why?
|
| Data Collection | 1 | 2012 | 399 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2023 | 2911 | 0.080 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 427 | 0.080 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 1990 | 152 | 0.080 |
Why?
|
| Receptors, LDL | 2 | 2009 | 102 | 0.080 |
Why?
|
| Cerebellar Diseases | 1 | 2011 | 81 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2017 | 1619 | 0.080 |
Why?
|
| Mice | 9 | 2023 | 19044 | 0.080 |
Why?
|
| Neurites | 2 | 2000 | 46 | 0.080 |
Why?
|
| Ginkgolides | 3 | 1998 | 8 | 0.080 |
Why?
|
| Pedigree | 3 | 2019 | 1698 | 0.080 |
Why?
|
| Glutamates | 1 | 1989 | 70 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 149 | 0.080 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2008 | 8 | 0.080 |
Why?
|
| Hydrocephalus | 2 | 2011 | 276 | 0.080 |
Why?
|
| Central Nervous System Cysts | 1 | 2008 | 12 | 0.080 |
Why?
|
| Glycine | 1 | 1990 | 173 | 0.080 |
Why?
|
| Kinetics | 3 | 2000 | 1357 | 0.070 |
Why?
|
| Volatilization | 1 | 2008 | 4 | 0.070 |
Why?
|
| Aldehydes | 1 | 2008 | 32 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2023 | 4012 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 826 | 0.070 |
Why?
|
| Calcium | 2 | 1990 | 1148 | 0.070 |
Why?
|
| Hypoglycemia | 1 | 1989 | 193 | 0.070 |
Why?
|
| Autistic Disorder | 2 | 2009 | 371 | 0.070 |
Why?
|
| Status Epilepticus | 1 | 1989 | 154 | 0.070 |
Why?
|
| Kynurenine | 1 | 1987 | 26 | 0.070 |
Why?
|
| Receptors, Lipoprotein | 1 | 2007 | 11 | 0.070 |
Why?
|
| Lissencephaly | 1 | 2007 | 10 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 5477 | 0.070 |
Why?
|
| Williams Syndrome | 1 | 2007 | 42 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2007 | 78 | 0.070 |
Why?
|
| Research Design | 6 | 2006 | 747 | 0.070 |
Why?
|
| Valine | 1 | 1987 | 116 | 0.070 |
Why?
|
| Exons | 2 | 2022 | 835 | 0.070 |
Why?
|
| Acute Disease | 1 | 2010 | 1192 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 1989 | 278 | 0.060 |
Why?
|
| Base Sequence | 3 | 2018 | 3177 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2024 | 3665 | 0.060 |
Why?
|
| Genotype | 3 | 2017 | 2807 | 0.060 |
Why?
|
| Diarrhea | 3 | 2021 | 342 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2007 | 317 | 0.060 |
Why?
|
| Child Behavior | 1 | 2007 | 235 | 0.060 |
Why?
|
| Munchausen Syndrome | 1 | 1984 | 4 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1999 | 1310 | 0.060 |
Why?
|
| Nasal Lavage Fluid | 1 | 2004 | 14 | 0.060 |
Why?
|
| Personnel Turnover | 1 | 2024 | 9 | 0.060 |
Why?
|
| Purpura | 1 | 1984 | 26 | 0.060 |
Why?
|
| Gestational Age | 2 | 2020 | 1227 | 0.060 |
Why?
|
| Chromosome Deletion | 3 | 2016 | 666 | 0.060 |
Why?
|
| Drosophila | 2 | 2023 | 829 | 0.050 |
Why?
|
| Body Patterning | 1 | 2004 | 130 | 0.050 |
Why?
|
| Erythrocytes | 1 | 1984 | 238 | 0.050 |
Why?
|
| Biopsy | 1 | 2017 | 1303 | 0.050 |
Why?
|
| Quinazolines | 1 | 2004 | 184 | 0.050 |
Why?
|
| WW Domain-Containing Oxidoreductase | 1 | 2022 | 4 | 0.050 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2003 | 22 | 0.050 |
Why?
|
| Transcription Factor HES-1 | 1 | 2002 | 20 | 0.050 |
Why?
|
| Contractile Proteins | 1 | 2002 | 18 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 7207 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 774 | 0.050 |
Why?
|
| Mitochondria | 2 | 2018 | 756 | 0.050 |
Why?
|
| Filamins | 1 | 2002 | 27 | 0.050 |
Why?
|
| Receptors, Neurotransmitter | 4 | 1990 | 22 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 485 | 0.050 |
Why?
|
| Choristoma | 1 | 2002 | 50 | 0.050 |
Why?
|
| Cilia | 1 | 2023 | 79 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 1984 | 279 | 0.050 |
Why?
|
| Microtubules | 2 | 2001 | 132 | 0.050 |
Why?
|
| Dyneins | 1 | 2001 | 13 | 0.050 |
Why?
|
| Molecular Motor Proteins | 1 | 2001 | 29 | 0.050 |
Why?
|
| Wheat Germ Agglutinins | 2 | 1992 | 14 | 0.050 |
Why?
|
| Child Abuse | 1 | 1984 | 203 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2021 | 17518 | 0.050 |
Why?
|
| COS Cells | 3 | 2009 | 284 | 0.050 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2003 | 121 | 0.050 |
Why?
|
| Dengue | 1 | 2002 | 122 | 0.040 |
Why?
|
| Point Mutation | 1 | 2002 | 361 | 0.040 |
Why?
|
| Receptors, Glutamate | 2 | 1992 | 18 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2002 | 143 | 0.040 |
Why?
|
| Testis | 1 | 2003 | 433 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 2 | 1998 | 136 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2002 | 289 | 0.040 |
Why?
|
| Growth Cones | 1 | 2000 | 16 | 0.040 |
Why?
|
| Dogs | 1 | 2021 | 798 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 377 | 0.040 |
Why?
|
| Leukocytes | 1 | 2021 | 223 | 0.040 |
Why?
|
| Mosaicism | 1 | 2002 | 247 | 0.040 |
Why?
|
| Carbohydrate Sequence | 1 | 2020 | 19 | 0.040 |
Why?
|
| Glycomics | 1 | 2020 | 16 | 0.040 |
Why?
|
| Internationality | 1 | 2021 | 138 | 0.040 |
Why?
|
| Gestational Trophoblastic Disease | 1 | 2020 | 10 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 139 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 406 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2020 | 71 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2024 | 574 | 0.040 |
Why?
|
| Academic Performance | 1 | 2020 | 25 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 128 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 510 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2000 | 300 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2020 | 158 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2002 | 585 | 0.040 |
Why?
|
| Membrane Potentials | 3 | 1990 | 319 | 0.040 |
Why?
|
| Nocodazole | 1 | 1999 | 11 | 0.040 |
Why?
|
| Cytochalasin D | 1 | 1999 | 11 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 1831 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 2793 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6602 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 103 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 717 | 0.040 |
Why?
|
| Craniofacial Abnormalities | 2 | 2011 | 250 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 13051 | 0.040 |
Why?
|
| Patient Safety | 1 | 2023 | 433 | 0.040 |
Why?
|
| Gene Expression | 1 | 2003 | 1621 | 0.040 |
Why?
|
| Time Factors | 3 | 1995 | 6604 | 0.040 |
Why?
|
| Embryo Implantation | 1 | 2020 | 235 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2934 | 0.040 |
Why?
|
| Dioxolanes | 1 | 1998 | 12 | 0.040 |
Why?
|
| Transaminases | 1 | 2018 | 36 | 0.040 |
Why?
|
| Paclitaxel | 1 | 1999 | 143 | 0.040 |
Why?
|
| Polymers | 1 | 1999 | 118 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2019 | 274 | 0.040 |
Why?
|
| Trisomy | 1 | 2018 | 112 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 1997 | 124 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 1997 | 125 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 294 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2017 | 106 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1137 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 356 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 3043 | 0.030 |
Why?
|
| Eyebrows | 1 | 2016 | 13 | 0.030 |
Why?
|
| Hypertelorism | 1 | 2016 | 11 | 0.030 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 160 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1997 | 402 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2016 | 3979 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2024 | 887 | 0.030 |
Why?
|
| Rabbits | 1 | 1997 | 729 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2004 | 2043 | 0.030 |
Why?
|
| Epithelium | 1 | 1997 | 366 | 0.030 |
Why?
|
| Actins | 1 | 1999 | 350 | 0.030 |
Why?
|
| Megalencephaly | 1 | 2016 | 58 | 0.030 |
Why?
|
| New York | 1 | 2016 | 73 | 0.030 |
Why?
|
| Anti-Asthmatic Agents | 1 | 1998 | 123 | 0.030 |
Why?
|
| Apoptosis | 1 | 2003 | 1945 | 0.030 |
Why?
|
| Methanol | 1 | 1995 | 18 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 29 | 0.030 |
Why?
|
| Fatigue | 1 | 2017 | 203 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2002 | 905 | 0.030 |
Why?
|
| Texas | 1 | 2004 | 3715 | 0.030 |
Why?
|
| Textiles | 1 | 2015 | 11 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 97 | 0.030 |
Why?
|
| Prognosis | 2 | 2021 | 5085 | 0.030 |
Why?
|
| Evoked Potentials | 2 | 1992 | 142 | 0.030 |
Why?
|
| Cytokines | 1 | 2021 | 1400 | 0.030 |
Why?
|
| Education, Distance | 1 | 2016 | 66 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 1997 | 466 | 0.030 |
Why?
|
| Phospholipids | 1 | 1995 | 114 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2016 | 163 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 1071 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 130 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 932 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 1338 | 0.030 |
Why?
|
| DDT | 1 | 2014 | 6 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1199 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 500 | 0.030 |
Why?
|
| Insecticide Resistance | 1 | 2014 | 39 | 0.030 |
Why?
|
| United States | 2 | 2020 | 11750 | 0.030 |
Why?
|
| Insect Proteins | 1 | 2014 | 111 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 562 | 0.030 |
Why?
|
| Tetrodotoxin | 2 | 1992 | 53 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 1786 | 0.030 |
Why?
|
| Lethal Dose 50 | 1 | 2013 | 19 | 0.030 |
Why?
|
| Protein Binding | 2 | 2009 | 1858 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1356 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 432 | 0.030 |
Why?
|
| Egtazic Acid | 2 | 1990 | 24 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 1993 | 38 | 0.030 |
Why?
|
| Bicuculline | 1 | 1992 | 21 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2011 | 707 | 0.030 |
Why?
|
| Triazoles | 1 | 1994 | 142 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 1997 | 937 | 0.020 |
Why?
|
| Fungi | 1 | 2013 | 75 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 1993 | 83 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2016 | 810 | 0.020 |
Why?
|
| Larva | 1 | 2013 | 262 | 0.020 |
Why?
|
| Long-Term Potentiation | 1 | 1994 | 163 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 1992 | 160 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1992 | 174 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1993 | 649 | 0.020 |
Why?
|
| Ion Channels | 1 | 1992 | 210 | 0.020 |
Why?
|
| Intracranial Thrombosis | 1 | 2011 | 12 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3753 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1987 | 236 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 1994 | 993 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 1990 | 25 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2011 | 199 | 0.020 |
Why?
|
| Neurotoxins | 1 | 1990 | 58 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 179 | 0.020 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2009 | 81 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2011 | 155 | 0.020 |
Why?
|
| Liver | 1 | 2017 | 1879 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2011 | 538 | 0.020 |
Why?
|
| Heterozygote | 1 | 2011 | 722 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1989 | 86 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 206 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2008 | 59 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2008 | 44 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2008 | 94 | 0.020 |
Why?
|
| Potassium Channels | 1 | 1989 | 166 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2008 | 167 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2008 | 123 | 0.020 |
Why?
|
| Karyotyping | 1 | 2008 | 324 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 152 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2008 | 145 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2008 | 146 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1987 | 14 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 400 | 0.020 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2007 | 9 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 1987 | 90 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 237 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 397 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2007 | 94 | 0.020 |
Why?
|
| Cell Survival | 1 | 1989 | 890 | 0.020 |
Why?
|
| Microcephaly | 1 | 2009 | 347 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 211 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 1140 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 793 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2007 | 177 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2008 | 363 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 1004 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 958 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 203 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2009 | 1712 | 0.010 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2004 | 14 | 0.010 |
Why?
|
| Magnesium Sulfate | 1 | 1984 | 50 | 0.010 |
Why?
|
| Injections | 1 | 1984 | 156 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 806 | 0.010 |
Why?
|
| Exanthema | 1 | 2004 | 71 | 0.010 |
Why?
|
| Ketamine | 1 | 1987 | 226 | 0.010 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2003 | 10 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 2539 | 0.010 |
Why?
|
| Isoleucine | 1 | 2003 | 30 | 0.010 |
Why?
|
| Blindness, Cortical | 1 | 2003 | 15 | 0.010 |
Why?
|
| Acids | 1 | 2003 | 31 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2004 | 303 | 0.010 |
Why?
|
| Puerto Rico | 1 | 2002 | 52 | 0.010 |
Why?
|
| Microtubule-Organizing Center | 1 | 2001 | 5 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2004 | 727 | 0.010 |
Why?
|
| Ependyma | 1 | 2001 | 7 | 0.010 |
Why?
|
| Choroid Plexus | 1 | 2001 | 24 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 158 | 0.010 |
Why?
|
| Lateral Ventricles | 1 | 2001 | 16 | 0.010 |
Why?
|
| Diet, Protein-Restricted | 1 | 2003 | 82 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 186 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2001 | 125 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 2858 | 0.010 |
Why?
|
| Receptors, AMPA | 2 | 1992 | 51 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2001 | 323 | 0.010 |
Why?
|
| Dengue Virus | 1 | 2002 | 134 | 0.010 |
Why?
|
| Cell Polarity | 1 | 2001 | 127 | 0.010 |
Why?
|
| Neocortex | 1 | 2001 | 76 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 2002 | 330 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1599 | 0.010 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2000 | 19 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 69 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 153 | 0.010 |
Why?
|
| Electrophysiology | 2 | 1992 | 282 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 328 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2000 | 163 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 4877 | 0.010 |
Why?
|
| Olfactory Bulb | 1 | 1998 | 103 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 1440 | 0.010 |
Why?
|
| Thienopyridines | 1 | 1994 | 1 | 0.010 |
Why?
|
| Tetrazoles | 1 | 1994 | 64 | 0.010 |
Why?
|
| Azepines | 1 | 1994 | 65 | 0.010 |
Why?
|
| Action Potentials | 1 | 1994 | 531 | 0.010 |
Why?
|
| Quisqualic Acid | 1 | 1990 | 4 | 0.010 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1990 | 6 | 0.010 |
Why?
|
| Cesium | 1 | 1989 | 15 | 0.000 |
Why?
|
| Potassium | 1 | 1989 | 290 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1987 | 81 | 0.000 |
Why?
|
| Anesthesia, General | 1 | 1987 | 125 | 0.000 |
Why?
|